Serial Number | 78355970 |
Word Mark | EPIGENESIS PHARMACEUTICALS |
Filing Date | Thursday, January 22, 2004 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, October 27, 2008 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, July 5, 2005 |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Disclaimer with Predetermined Text | PHARMACEUTICALS |
Goods and Services | Medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 2, 2004 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | EPIGENESIS PHARMACEUTICALS LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | CRANBURY, NJ 08512 |
Party Name | EPIGENESIS PHARMACEUTICALS LLC |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 03 - Corporation |
Address | CRANBURY, NJ 08512 |
Party Name | EPIGENESIS Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cranbury, NJ 08512 |
Event Date | Event Description |
Monday, October 27, 2008 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Monday, October 27, 2008 | ABANDONMENT - NO USE STATEMENT FILED |
Friday, April 4, 2008 | EXTENSION 5 GRANTED |
Friday, March 14, 2008 | EXTENSION 5 FILED |
Friday, March 14, 2008 | TEAS EXTENSION RECEIVED |
Wednesday, September 26, 2007 | EXTENSION 4 GRANTED |
Thursday, September 13, 2007 | EXTENSION 4 FILED |
Thursday, September 13, 2007 | TEAS EXTENSION RECEIVED |
Thursday, June 28, 2007 | EXTENSION 3 GRANTED |
Tuesday, March 20, 2007 | EXTENSION 3 FILED |
Tuesday, March 20, 2007 | TEAS EXTENSION RECEIVED |
Tuesday, October 24, 2006 | EXTENSION 2 GRANTED |
Friday, September 22, 2006 | EXTENSION 2 FILED |
Friday, September 22, 2006 | TEAS EXTENSION RECEIVED |
Friday, April 28, 2006 | EXTENSION 1 GRANTED |
Friday, March 24, 2006 | EXTENSION 1 FILED |
Friday, March 24, 2006 | TEAS EXTENSION RECEIVED |
Tuesday, September 27, 2005 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, July 5, 2005 | PUBLISHED FOR OPPOSITION |
Wednesday, June 15, 2005 | NOTICE OF PUBLICATION |
Monday, March 28, 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Friday, March 25, 2005 | ASSIGNED TO LIE |
Friday, March 18, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, March 17, 2005 | AMENDMENT FROM APPLICANT ENTERED |
Monday, January 31, 2005 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, January 31, 2005 | PAPER RECEIVED |
Tuesday, October 5, 2004 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Saturday, August 21, 2004 | NON-FINAL ACTION E-MAILED |
Thursday, August 12, 2004 | ASSIGNED TO EXAMINER |
Tuesday, July 20, 2004 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Friday, July 16, 2004 | PAPER RECEIVED |
Monday, February 2, 2004 | NEW APPLICATION ENTERED IN TRAM |